EP3639843 - APOO FOR USE IN A METHOD FOR TREATING CANCER AND VARIOUS PATHOPHYSIOLOGICAL SITUATIONS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.11.2021 Database last updated on 09.09.2024 | |
Former | Examination is in progress Status updated on 22.01.2021 | ||
Former | Request for examination was made Status updated on 20.03.2020 | Most recent event Tooltip | 26.11.2021 | Application deemed to be withdrawn | published on 29.12.2021 [2021/52] | Applicant(s) | For all designated states Rouet, Philippe 485 chemin de riverotte 31810 Clermont le fort / FR | For all designated states Smih-Rouet, Fatima 485 chemin de riverotte 31810 Clermont le fort / FR | [2020/17] | Inventor(s) | 01 /
see applicant ... | [2020/17] | Representative(s) | Plasseraud IP 104 Rue de Richelieu CS92104 75080 Paris Cedex 02 / FR | [N/P] |
Former [2020/17] | Plasseraud IP 66, rue de la Chaussée d'Antin 75440 Paris Cedex 09 / FR | Application number, filing date | 19214261.0 | 15.04.2015 | [2020/17] | Priority number, date | EP20140305565 | 16.04.2014 Original published format: EP 14305565 | [2020/17] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3639843 | Date: | 22.04.2020 | Language: | EN | [2020/17] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 12.02.2020 | Classification | IPC: | A61K38/17, A61P35/00, A61P3/00 | [2020/17] | CPC: |
A61K38/1709 (EP,US);
A61K38/1716 (EP,US);
A61P35/00 (EP,US);
C07K16/18 (US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/17] | Title | German: | APOO ZUR VERWENDUNG IN EINEM VERFAHREN ZUR BEHANDLUNG VON KREBS UND VERSCHIEDENEN PATHOPHYSIOLOGISCHEN ZUSTÄNDEN | [2020/17] | English: | APOO FOR USE IN A METHOD FOR TREATING CANCER AND VARIOUS PATHOPHYSIOLOGICAL SITUATIONS | [2020/17] | French: | APOO POUR UTILISATION DANS UN PROCÉDÉ DE TRAITEMENT DU CANCER ET DIVERSES SITUATIONS PATHOPHYSIOLOGIQUES | [2020/17] | Examination procedure | 06.12.2019 | Examination requested [2020/17] | 22.10.2020 | Amendment by applicant (claims and/or description) | 25.01.2021 | Despatch of a communication from the examining division (Time limit: M06) | 05.08.2021 | Application deemed to be withdrawn, date of legal effect [2021/52] | 25.08.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2021/52] | Parent application(s) Tooltip | EP15716524.2 / EP3131569 | Fees paid | Renewal fee | 06.12.2019 | Renewal fee patent year 03 | 06.12.2019 | Renewal fee patent year 04 | 06.12.2019 | Renewal fee patent year 05 | 27.10.2020 | Renewal fee patent year 06 | 09.04.2021 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 30.04.2020 | 06   M06   Fee paid on   27.10.2020 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2013183964 (UNIV SOGANG IND UNIV COOP FOUN [KR]) [Y] 1-15 * the whole document * * claim 12 *; | [I]WO2012072681 (INST NAT SANTE RECH MED [FR], et al) [I] 1-15 * the whole document * * claims 9-10 * * page 29, line 18 * * page 16, lines 5-6 *; | [XP] - TURKIEH ANNIE ET AL, "Apolipoprotein O is mitochondrial and promotes lipotoxicity in heart.", THE JOURNAL OF CLINICAL INVESTIGATION 1 MAY 2014, (20140501), vol. 124, no. 5, ISSN 1558-8238, pages 2277 - 2286, XP002725819 [XP] 1-15 * the whole document * DOI: http://dx.doi.org/10.1172/JCI74668 | [Y] - CHEN-LU WU ET AL, "Microarray analysis provides new insights into the function of apolipoprotein O in HepG2 cell line", LIPIDS IN HEALTH AND DISEASE, BIOMED CENTRAL, LONDON, GB, (20131217), vol. 12, no. 1, doi:10.1186/1476-511X-12-186, ISSN 1476-511X, page 186, XP021171320 [Y] 1-15 * the whole document * * abstract * DOI: http://dx.doi.org/10.1186/1476-511X-12-186 | [Y] - MATTHIEU LAMANT ET AL, "ApoO, a Novel Apolipoprotein, Is an Original Glycoprotein Up-regulated by Diabetes in Human Heart", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, vol. 281, no. 47, doi:10.1074/JBC.M510861200, ISSN 0021-9258, (20061124), pages 36289 - 36302, (20060906), XP002627267 [Y] 1-15 * the whole document * DOI: http://dx.doi.org/10.1074/jbc.M510861200 | by applicant | US4946778 | US5225539 | US4816397 | US6573099 | US6506559 | WO0136646 | WO9932619 | WO0168836 | - "database", Database accession no. NM_024122 | - CARTER et al., Nucl. Acids Res., (19850000), vol. 13, page 4331 | - HARMANCEY, R. et al., "western diet changes cardiac acyl-CoA composition in obese rats: a potential role for hepatic lipogenesis", J Lipid Res, (20100000), vol. 51, pages 1380 - 1393 | - HICKSON-BICK et al., J Mol Cell Cardiol, (20000000), vol. 32, pages 511 - 519 | - HIROTA et al., Life Sci, (20060000), vol. 79, pages 1312 - 1316 | - ASKARI, B. et al., Diabetes, (20070000), vol. 56, pages 1143 - 1152 |